CClinicalTrials.gg
CompletedNCT03289546Updated Feb 20, 2019

The Active Mind Study

An interventional study of Mindfulness training and Aerobic training in Cognitive Impairment and Cardiovascular Risk Factor, sponsored by The Miriam Hospital. Completed at 1 site in United States. Open to participants aged 55 Years and older. Per ClinicalTrials.gov, last updated 2019-02-20.

Sponsored by The Miriam Hospital · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
55 Years and older
Sex
All
01

Study summary

The purpose of this study is to explore whether physical exercise, mindfulness training, or both interventions together can improve cognitive function in individuals with multiple risk factors for the development of dementia in the future.

Read the detailed description

The investigators will test the feasibility and acceptability of a combined mindfulness training + aerobic training intervention, vs. either alone or none to improve cognitive function in older adults with cognitive impairment. The investigators will also obtain estimates of effect sizes (and confidence intervals) on cognitive function. Preliminary analyses will be conducted to explore the mediating role of changes in aerobic capacity, physical activity, vascular risk factors, and mindfulness skills. Assessments will be conducted at baseline, 3-, and 6- months since baseline.

02

Conditions studied

  • Cognitive Impairment
  • Cardiovascular Risk Factor

Keywords

  • mindfulness
  • exercise
  • cognitive function
03

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age ≥55
  2. Being physically inactive (defined as not meeting current AHA recommendations for physical activity, i.e., \< 150 min of moderate-intensity aerobic activity per week OR \< 75 minutes of vigorous aerobic activity per week
  3. Cognitive complaint defined as answering yes to the question "do you feel that your memory or thinking skills have gotten worse recently?"
  4. Fluency in English language

Exclusion criteria

Exclusion Criteria:

  1. Unwillingness/inability to provide informed consent
  2. Contraindications to physical activity as per the participant's PCP assessment
  3. Blood pressure >200/110
  4. Severe depressive symptoms (defined as Hospital Anxiety and Depression Scale [HADS] depression subscale scores >14)
  5. Acute psychosis (from medical record)
  6. Severe cognitive impairment (Mini-Mental State Examination [MMSE] score \<24)
  7. Recent hospitalization (\< 6 weeks)
  8. Current (at least once a month) mind/body practice (i.e., mindfulness meditation, yoga, or tai chi)
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
38 participants (actual)

Study arms

  • Experimental
    Mindfulness training only

    1 mindfulness training class (1 hour) every week for 8 weeks.

    Behavioral: Mindfulness training

  • Experimental
    Aerobic training only

    3 aerobic training sessions (1 hour) per week for 12 weeks.

    Behavioral: Aerobic training

  • Experimental
    mindfulness + aerobic training

    2 aerobic training sessions + 1 mindfulness training class every week for 8 weeks, then continue with 3 aerobic training sessions/ week for 4 additional weeks.

    Behavioral: Mindfulness training · Behavioral: Aerobic training

  • No intervention
    Usual care

Interventions

  • BehavioralMindfulness training

    The mindfulness training protocol will include the following basic components of traditional mindfulness-based stress reduction training: 1) training in awareness of sensations ("body scan"); 2) training in the awareness of the sensations of breathing; 3) training in directing the attention to simple activities of daily life, and in recognizing when the attention is no longer focused on a specific object of attention; and 4) training in 'open awareness'.

  • BehavioralAerobic training

    Exercise sessions will be led by CPR- and exercise-certified YMCA instructors and supervised by the senior research assistant. Sessions will consist of 10 minutes of warm-up, 40 minutes of aerobic exercise (walking on a treadmill), 10 minutes of cool down and stretching. Participants will receive heart monitors at the beginning of the study and will be trained by the senior research assistant to exercise targeting heart rates at 65-75% of the age predicted max heart rate or at an intensity of 12-13 in the Borg scale of the rate of perceived exertion.

05

What researchers measure

Primary outcomes

  1. Retention rates of 80% at the final follow-up visit

    The investigators will consider the study feasible under this condition

    Time frame: 3 months from baseline

  2. Number of participants who attended at least 70% of the planned sessions

    The investigators will consider the study feasible under this condition

    Time frame: 3 months from baseline

  3. Number of participants who completed 70% of the assigned individual home practice exercises

    The investigators will consider the study feasible under this condition

    Time frame: 3 months from baseline

  4. Acceptability will be assessed using a satisfaction survey

    Acceptability will be assessed using a satisfaction survey. The intervention will be considered acceptable if ≥80% of participants responds that they are at least somewhat satisfied with the intervention.

    Time frame: 3 months from baseline

Secondary outcomes

  1. Effect size on cognitive function

    Preliminary estimates of effect size of mindfulness training alone vs. aerobic training alone, both, or neither on changes from baseline cognitive function.

    Time frame: baseline, 3, 6 months

  2. An exploratory outcome: Mindfulness will be assessed using the Five Facets of Mindfulness questionnaire (short form)

    Five Facets of Mindfulness questionnaire (short form) is a 12-item questionnaire that measures the five identified components of mindfulness meditation: observing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience.

    Time frame: baseline, 3, 6 months

  3. An exploratory outcome: Depression will be assessed using the Hospital Anxiety and Depression Scale (HADS)

    The HADS is a self-administered questionnaire with two sub-scales (0-21) measuring anxiety and depression, with higher scores indicating greater psychological morbidity

    Time frame: baseline, 3, 6 months

  4. Exploratory outcome: waist-to-hip ratio

    waist-to-hip ratio

    Time frame: baseline, 3, 6 months

  5. An exploratory outcome: Exercise capacity will be assessed via the 6 minute walking test

    The 6 minute walking test

    Time frame: baseline, 3, 6 months

  6. Exploratory outcome: blood pressure

    blood pressure

    Time frame: baseline, 3, 6 months

  7. An exploratory outcome: Social support will be assessed using the Multidimensional Scale of Perceived Social Support

    A 12-item, uni-dimensional tool to measure how one perceives their social support system, including individuals sources of social support (i.e., family, friends, and significant other).

    Time frame: baseline, 3, 6 months

06

Study locations

1 site
  • The Miriam Hospital
    Providence, Rhode Island 02906, United States
07

References and documents

Publications

  • Salmoirago-Blotcher E, DeCosta J, Harris K, Breault C, Dunsiger S, Santos C, Snyder P. Exploring synergistic effects of aerobic exercise and mindfulness training on cognitive function in older adults: Protocol for a pilot randomized controlled trial. Medicine (Baltimore). 2018 May;97(21):e10626. doi: 10.1097/MD.0000000000010626. PubMed 29794738 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03289546
Lead sponsor
The Miriam Hospital
Responsible party
Elena Salmoirago-Blotcher (Assistant professor of Medicine, The Miriam Hospital) — Principal investigator
First posted
Sep 21, 2017
Start date
Apr 1, 2016
Primary completion
Nov 30, 2018
Completion
Dec 31, 2018
Last update
Feb 20, 2019

Study contacts

Elena Salmoirago-Blotcher, PhD, MD
principal investigator · The Miriam Hospital & Warren Alpert Medical School at Brown University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion